Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney Disease
Conditions: Interstitial Lung Disease; Chronic Kidney Diseases Interventions: Biological: AD-214; Other: Placebo Sponsor: AdAlta Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Chronic Kidney Disease | Interstitial Lung Disease | Research | Study | Urology & Nephrology